


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.51%
-1.41%
+1.86%
+2.64%
-1.18%
ALC
Alcon Ordinary
$78.69
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
ALC Price Performance
$78.8 (-0.14%)
$73.99 (+6.35%)
$90.12 (-12.68%)
$91.26 (-13.77%)
ALC has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

ALC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
ALC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ALC Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
ALC
Alcon Ordinary
78.69
-2.66%
SAP
SAP
246.35
-1.13%
NFGC
New Found Gold
2.98
-6.45%
GWRE
Guidewire Software I
178.99
-1.14%
GSK
GlaxoSmithKline PLC
49.95
-0.87%
What is ALC current stock price?
What are ALC stock strengths?
What is ALC Risk Level?
What is ALC market cap and volume?
What is ALC current Stock IQ?
Should I buy ALC stock right now?
Is ALC a Strong Buy right now?
What does a 'Strong Buy' rating mean for ALC?
What does a 'Strong Sell' rating mean for ALC?
What factors influence ALC's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.51%
-1.41%
+1.86%
+2.64%
-1.18%
ALC
Alcon Ordinary
Current Price
$78.69
ALC Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Recently Viewed
ALC
Alcon Ordinary
78.69
-2.66%
SAP
SAP
246.35
-1.13%
NFGC
New Found Gold
2.98
-6.45%
GWRE
Guidewire Software I
178.99
-1.14%
GSK
GlaxoSmithKline PLC
49.95
-0.87%

ALC Price Performance
$78.8 (-0.14%)
$73.99 (+6.35%)
$90.12 (-12.68%)
$91.26 (-13.77%)
ALC Analysts Opinion
ALC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
ALC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ALC Street Sentiment is extremely bullish and have negative views on the near-term outlook
ALC has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
ALC Latest Analysis
Alcon terminates agreement to purchase STAAR Surgical.
Wed Jan 7, 2026
Alcon Terminates Merger Agreement With STAAR Surgical . (RTTNews) - Alcon (ALC) announced Tuesday that it terminated its definitive merger agreement with STAAR Surgical Company (STAA) announced on August 5 2025.
Wed Jan 7, 2026
STAAR Stock Drops 10% After Shareholders Reject Alcon Merger Proposal . (RTTNews) - STAAR Surgical Company (STAA) shares fell 10.23% trading at $21.49 down $2.45 following news that the company will terminate its merger agreement with Alcon Inc. after failing to secure enough shareholder votes at a special meeting.
Tue Jan 6, 2026
STAAR Surgical Merger With Alcon Fails After Shareholders Vote No. STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with ) at the Special .STAAR intends to terminate its merger agreement with Alcon.No termination fee will be payable by either party and STAAR will remain a standalone publicly traded company.Stephen Farrell CEO of STAAR said “.….In the short term we will continue to prioritize profitable sales growth while we
Tue Jan 6, 2026
STAAR Surgical sinks as it plans to terminate sale to Alcon.
Tue Jan 6, 2026
Falcon Oil & Gas Ltd. - Approval for the sale of Falcons 98.1% interest in Falcon Oil & Gas Australia Limited to Tamboran group.. Falcon Oil &. Gas Ltd. (Falcon)Approval for the sale of Falcon'.s 98.1% interest in Falcon Oil &. Gas Australia Limited to Tamboran group. AIM: FOG)) subsidiary company Falcon Oil &. Gas Australia Limited (Falcon Australia) held a General Meeting in Brisbane Australia on 30 December 2025. ASX: TBN)) (Tamboran group). Falcon and its associates were exclude
Mon Jan 5, 2026
Falcon Oil & Gas Ltd. - Approval for the sale of Falcons 98.1% interest in Falcon Oil & Gas Australia Limited to Tamboran group.. Falcon Oil &. Gas Ltd. (Falcon)
Mon Jan 5, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.